KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amneal Pharmaceuticals (AMRX) Depreciation & Amortization (CF) (2017 - 2025)

Amneal Pharmaceuticals (AMRX) has 9 years of Depreciation & Amortization (CF) data on record, last reported at $49.2 million in Q4 2025.

  • For Q4 2025, Depreciation & Amortization (CF) fell 25.56% year-over-year to $49.2 million; the TTM value through Dec 2025 reached $223.6 million, down 5.34%, while the annual FY2025 figure was $223.6 million, 5.34% down from the prior year.
  • Depreciation & Amortization (CF) reached $49.2 million in Q4 2025 per AMRX's latest filing, down from $54.1 million in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $66.1 million in Q4 2024 and bottomed at $49.2 million in Q4 2025.
  • Average Depreciation & Amortization (CF) over 5 years is $58.1 million, with a median of $58.0 million recorded in 2022.
  • Peak YoY movement for Depreciation & Amortization (CF): grew 16.15% in 2024, then fell 25.56% in 2025.
  • A 5-year view of Depreciation & Amortization (CF) shows it stood at $61.2 million in 2021, then fell by 0.21% to $61.1 million in 2022, then decreased by 6.75% to $56.9 million in 2023, then grew by 16.15% to $66.1 million in 2024, then dropped by 25.56% to $49.2 million in 2025.
  • Per Business Quant database, its latest 3 readings for Depreciation & Amortization (CF) were $49.2 million in Q4 2025, $54.1 million in Q3 2025, and $60.1 million in Q2 2025.